Tag: Ncardia

Ncardia Launches Ncyte® Heart in a Box to Advance Cardiovascular Research and Precision Medicine

Coronary/Structural Heart by 0 comments

LEIDEN, The Netherlands–(BUSINESS WIRE)–Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart in a Box, a breakthrough 3D cardiac microtissue model designed to drive innovation in cardiovascular research and drug discovery. “With Ncyte® Heart in a Box, we are empowering researchers to […]

Continue Reading →

Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes

Coronary/Structural Heart by 0 comments

LEIDEN, the Netherlands & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ncardia and BlueRock Therapeutics today announced an agreement covering process development technologies for the manufacture of induced pluripotent stem cell (iPSC)-derived cardiomyocytes. Under the terms of the agreement, Bluerock gains access to Ncardia’s large-scale production processes and intellectual property for the production of iPSC-derived […]

Continue Reading →